Does CBER publish a list of all current Investigational New Drugs (IND) and Biologics License Applications (BLA)?
Answer
No, federal regulations (21CFR 601.50 and 601.51) prohibit CBER from acknowledging the existence of, or disclosing information on, any product which may or may not be under reveiw by the Center.
